InsiderTrades

Form 4 for NPKI NPK International Inc.

Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0001975485-26-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-10 2026-03-06 NPKI Fruge Mary Celeste VP, GC S - Sale+OE $13.34 -11.2K 265.2K -4% -$149.3K
D 2026-03-10 2026-03-06 NPKI Fruge Mary Celeste VP, GC M - OptEx $4.32 +11.2K 276.4K +4% +$48.4K
D 2026-03-10 2026-03-06 NPKI Fruge Mary Celeste VP, GC M - OptEx $0.00 -11.2K 1,000 -92% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-06 S D 11,193 $13.34 265,213 D — — (F1) The reported exercise of 11,193 options and subsequent sale of the shares acquired upon exercise occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2025. (F2) The price reported is the weighted average price. These options were sold in multiple transactions in the open market at prices ranging from $13.24 to $13.48, inclusive. The reporting person undertakes to provide to NPK International Inc., any security holder of NPK International Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of options sold at each separate price within the range set forth in footnote (2) to this Form 4.
2 Common Common Stock 2026-03-06 M A 11,193 $4.32 276,406 D — — (F1) The reported exercise of 11,193 options and subsequent sale of the shares acquired upon exercise occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2025.
3 Derivative Non-Qualified Stock Option (right to buy) 2026-03-06 M D 11,193 $0.00 1,000 D $4.32 · 2019-06-01 to 2026-05-19 11,193 Common Stock (F1) The reported exercise of 11,193 options and subsequent sale of the shares acquired upon exercise occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2025.